✦ LIBER ✦

Pharmaceutical downsizing and oncology drug development

✍ Scribed by Kathryn Senior

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

MR in oncology drug development

✍ Susan M. Galbraith 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 333 KB

Biomarkers in oncology drug development

✍ Darren R. Hodgson; Robin D. Whittaker; Athula Herath; Dereck Amakye; Glen Clack 📂 Article 📅 2008 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 303 KB

New drug development for pediatric oncol

✍ Steven Weitman; Lisa Carlson; Charles B. Pratt 📂 Article 📅 1996 🏛 Springer US 🌐 English ⚖ 838 KB

Economics of New Oncology Drug Developme

✍ DiMasi, J. A.; Grabowski, H. G. 📂 Article 📅 2007 🏛 American Society of Clinical Oncology 🌐 English ⚖ 148 KB

236 INVITED Challenges of drug developme

✍ R. Capdeville 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 59 KB

Pharmaceutical solid polymorphism in dru

✍ Andre S. Raw; Lawrence X. Yu 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 63 KB